Expanding access Strong consumer direct testing capabilities via My Lab Request and recent GLP-1 Progress Panel launch indicate opportunities to upsell direct-to-consumer or self-collection pathways, especially for chronic disease monitoring and specialty panels.

Affordability initiatives Care Within Reach program demonstrates a focus on reducing out-of-pocket barriers, suggesting partnerships with payers, employer health programs, and community clinics to expand access to essential lab testing.

Strategic partnerships Existing collaboration with Banner Health and Quest Diagnostics, plus recent NAH partnership for STAT processing, imply room to scale joint ventures, regional lab network expansions, and faster turnaround services for hospitals.

Digital & analytics strength Technology stack including Power Automate, Tableau, AWS, and monitoring tools points to data-driven sales plays, such as bundled analytics services, population health testing packages, and remote ordering efficiencies.

Diverse test menu 300+ tests across routine, molecular, genetic/genomic, women’s health, and pathology combined with rapid test initiatives creates cross-sell potential into specialty programs for fertility, HPV, and personalized medicine.